MedTrace Logo

Wound Healing Following Tooth Extraction and Ridge Preservation Using DFDBA Alone in Particulate Fiber Form and in Combination With Xenograft

NCT05400213 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2025-06-19

Study results available
· View outcomes & findings →

Summary

The primary aim of the study is to determine the amount of newly formed vital bone, residual graft material, and "connective tissue/other" 18 to 20 weeks after ridge preservation is performed using DFDBA fibers alone, DFDBA particulate alone, a combination of xenograft and DFDBA particulate, or a combination of xenograft and DFDBA fibers.

Conditions

  • Dental Extraction
  • Wound Heal

Interventions

DEVICE

Vallos (DCP)

Demineralized freeze-dried bone allograft (DFBA) in a small particle form

DEVICE

Vallomix (DCF)

A combination of cow-derived xenograft and human-derived DFDBA particulate

DEVICE

Vallos-F (DPX)

Demineralized freeze-dried bone allograft (DFDBA) in a fiber form

DEVICE

Vallomix-F (DFX)

A combination of cow-derived xenograft and human-derived DFDBA fibers

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Brian Mealey, DDS, MS · University of Texas Health Science Center San Antonio

  • Angela Palaiologou-Gallis, DDS · University of Texas Health Science Center San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-02
Primary Completion
2024-08-23
Completion
2024-12-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05400213 on ClinicalTrials.gov